Free. Unsubscribe any time.
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc filed 10 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 14 transactions and 351,000 shares. None carries the SEC's AFF10B5ONE flag; all 10 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-10, came 29 days after the one before it (2026-08-12) and reports 9 transactions against 6 in the filing before it.
- The sales it reports total 125,000 shares, 25,000 more than the 100,000 in the filing before it.
- Its 10 plan statements rank 385th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 5 have more plan statements on file than it and 5 have fewer.
- Its 10 filings on file run from 2025-03-19 to 2026-09-10, and state 3 plan adoption dates, from 2023-11-10 to 2026-02-27.
Trades in Protagonist Therapeutics, Inc 14
- Waddill William D. — 2025-03-17 · S · 4,000 shares
- Waddill William D. — 2025-08-27 · S · 4,000 shares
- Waddill William D. — 2025-09-22 · S · 4,000 shares
- Waddill William D. — 2025-10-10 · S · 4,000 shares
- Waddill William D. — 2025-10-10 · S · 8,000 shares
- PATEL DINESH V PH D — 2026-05-12 · S · 75,000 shares
- Waddill William D. — 2026-05-29 · S · 9,000 shares
- Waddill William D. — 2026-06-10 · S · 9,000 shares
- Waddill William D. — 2026-06-23 · S · 9,000 shares
- PATEL DINESH V PH D — 2026-08-10 · S · 65,761 shares
- PATEL DINESH V PH D — 2026-08-11 · S · 34,239 shares
- PATEL DINESH V PH D — 2026-09-08 · S · 54,174 shares
Adoption dates in Protagonist Therapeutics, Inc 3
- 2023-11-10 — stated in 4 filings
- 2026-01-30 — stated in 3 filings
- 2026-02-27 — stated in 3 filings
Results prints in Protagonist Therapeutics, Inc 7
- 2025-02-21
- 2025-05-06
- 2025-08-06
- 2025-11-06
- 2026-02-25
- 2026-05-05
- 2026-08-05
Trades before a print in Protagonist Therapeutics, Inc 0
- 27 days before the 2025-11-06 print — 2025-10-10 · S · Waddill William D. · 4,000 shares
- 27 days before the 2025-11-06 print — 2025-10-10 · S · Waddill William D. · 8,000 shares
- 43 days before the 2026-08-05 print — 2026-06-23 · S · Waddill William D. · 9,000 shares
- 45 days before the 2025-11-06 print — 2025-09-22 · S · Waddill William D. · 4,000 shares
- 50 days before the 2025-05-06 print — 2025-03-17 · S · Waddill William D. · 4,000 shares
- 56 days before the 2026-08-05 print — 2026-06-10 · S · Waddill William D. · 9,000 shares
- 68 days before the 2026-08-05 print — 2026-05-29 · S · Waddill William D. · 9,000 shares
- 71 days before the 2025-11-06 print — 2025-08-27 · S · Waddill William D. · 4,000 shares
- 85 days before the 2026-08-05 print — 2026-05-12 · S · PATEL DINESH V PH D · 75,000 shares
Interval to Protagonist Therapeutics, Inc’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 27shortest, days
- 5no later print
Adoption dates Protagonist Therapeutics, Inc states
- 2023-11-10 in 4 filings
- 2026-01-30 in 3 filings
- 2026-02-27 in 3 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on November 10, 2023”
Reported results dates on file
- 2025-02-21
- 2025-05-06
- 2025-08-06
- 2025-11-06
- 2026-02-25
- 2026-05-05
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.